Overview

A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

Status:
Terminated
Trial end date:
2020-01-30
Target enrollment:
Participant gender:
Summary
A ten-week study to assess MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression
Phase:
Phase 2
Details
Lead Sponsor:
Mediti Pharma Inc.